Thailand and Japan Make Progress in CAR T-Cell Cancer Immunotherapy
-
Loading... - Gamon Makok
- 19 Apr 2023
- 71 Views
- 0 Like
- 0 Comment
Thailand’s Chulalongkorn University and Japan’s Nagoya University are collaborating on the development of a form of immunotherapy designed to cure cancer.
In a recent conference entitled "CAR T-Cell Cancer Therapy Innovation: New Hope for Thai Cancer Patients," the teams reported on the progress of CAR T-cell immunotherapy. The treatment can increase survival rates and reduce the chance of cancer returning in leukemia and B-cell lymphoma patients.
CAR T-cell (Chimeric Antigen Receptor T-cell) therapy is a type of immunotherapy used to treat cancer. It involves genetically modifying a patient’s T-cells, which are a form of immune response, to specifically target cancer cells.
CAR T-cell cancer therapy is considered an efficient method of treating cancer via. The technology requires the production of CAR T-cells in a specialized sterile laboratory by genetically modifying a patient’s T cells and multiplying them outside the body until a sufficient number is achieved.
Infusing these cells back into the patient’s body can kill remaining cancer cells, especially in the circulatory system, where the innovation controls cancer in 50 to 80% of patients who were previously unresponsive to other forms of treatment. Read More…
